Lawal AO, Adisa AO, Kolude B, Adeyemi BF. Immunohistochemical expression of MMP-2 and MMP-8 in oral squamous
cell carcinoma. J Clin Exp
Dent. 2015;7(2):e203-7.
doi:10.4317/jced.52047
References
|
1. Sankaranarayanan
R, Masuyer E, Swaminathan
R, Ferlay J, Whelan S. Head and neck cancer: a
global perspective on epidemiology and prognosis. Anticancer Res. 1998;18:4779-86. |
|
|
|
|
|
2. Carvalho
AL, Ikeda MK, Magrin J, Kowalski LP. Trends of oral
and oropharyngeal cancer survival over five decades
in 3267 patients treated in a single institution. Oral Oncol. 2004;40:71-6. PMid:14662418 |
|
|
|
|
|
3. Lee JI, Jin BH, Kim MA, Yoon HJ, Hong
SP, Hong SD. Prognostic significance of CXCR-4 expression in oral squamous cell carcinoma. Oral Surg
Oral Med Oral Pathol Oral Radiol
Endod. 2009;107:678-84. |
|
|
|
|
|
4. Egeblad M, Werb Z. New functions for the matrix metalloproteinases
in cancer progression. Nat Rev Cancer. 2002;2:161-74. |
|
|
|
|
|
5. Westermarck J, Kähäri
VM. Regulation of matrix metalloproteinase expression in tumor invasion. FASEB J. 1999;13:781-92. |
|
|
|
|
|
6. Decock J, Hendrickx W, Vanleeuw U, Van
Belle V, Van Huffel S, Christiaens
MR, et al. Plasma MMP1 and MMP8 expression in breast cancer: protective role
of MMP8 against lymph node metastasis. BMC Cancer. 2008;8:77. |
|
|
|
|
|
7. Fan HX, Li HX, Chen D, Gao ZX, Zheng JH. Changes in
the expression of MMP2, MMP9, and ColIV in stromal cells in oral squamous
tongue cell carcinoma: relationships and prognostic implications. J Exp Clin Cancer Res. 2012;31:90. |
|
|
|
|
|
8. Andreadis D, Epivatianos
A, Poulopoulos A, Nomikos
A, Papazoglou G, Antoniades
D, et al. Detection of C-KIT (CD117) molecule in
benign and malignant salivary gland tumours. Oral Oncol. 2006;42:57-65. |
|
|
|
|
|
9. Subhashraj
K, Orafi M, Nair KV, El-Gehani
R, Elarbi M. Primary malignant tumors of orofacial region at Benghazi, Libya: a 17 years review. Cancer Epidemiol. 2009;33:332-6. |
|
|
|
|
|
10. Andisheh-Tadbir
A, Mehrabani D, Heydari
ST. Epidemiology of squamous cell carcinoma of the
oral cavity in Iran. J Craniofac Surg. 2008;19:1699-702. |
|
|
|
|
|
11. Pires FR, Ramos AB, Oliveira JB,
Tavares AS, Luz PS, Santos TC. Oral squamous cell carcinoma: clinicopathological
features from 346 cases from a single oral pathology service during an 8-year
period. J Appl Oral Sci. 2013;21:460-7. |
|
|
|
|
|
12. Chidzonga
MM, Mahomva L. Squamous
cell carcinoma of the oral cavity, maxillary antrum
and lip in a Zimbabwean population: a descriptive epidemiological study. Oral Oncol. 2006;42:184-9. |
|
|
|
|
|
13. Effiom OA, Adeyemo
WL, Omitola OG, Ajayi OF,
Emmanuel MM, Gbotolorun OM. Oral squamous cell carcinoma: a clinicopathologic review of 233 cases in Lagos, Nigeria. J Oral Maxillofac Surg. 2008;66:1595-9. |
|
|
|
|
|
14. Otoh EC,
Johnson NW, Olasoji H, Danfillo
IS, Adeleke OA. Salivary gland neoplasms
in Maiduguri, north-eastern Nigeria. Oral Dis. 2005;
11:386-91. |
|
|
|
|
|
15. Fernández-García
MS, Teruya-Feldstein J. The diagnosis and treatment
of dyskeratosis congenita:
a review. J Blood Med. 2014;21;5:157-67. PMid:25170286 |
|
|
|
|
|
16. Mashhadiabbas
F, Mahjour F, Mahjour SB,
Fereidooni F, Hosseini
FS. The immunohistochemical characterization of
MMP-2, MMP-10, TIMP-1, TIMP-2, and podoplanin in
oral squamous cell carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol. 2012;114:240-50. |
|
|
|
|
|
17. Mohtasham
N, Babakoohi S, Shiva A, Shadman
A, Kamyab-Hesari K, Shakeri
MT, et al. Immunohistochemical study of p53, Ki-67,
MMP-2 and MMP-9 expression at invasive front of squamous
cell and verrucous carcinoma in oral cavity. Pathol Res Pract. 2013;209:110-4. |
|
|
|
|
|
18. Duffy MJ, McGowan PM, Gallagher WM.
Cancer invasion and metastasis: changing views. J Pathol.
2008;214:283-93. |
|
|
|
|
|
19. Tang ZG, Li JM, Hong ZZ, Yu ZW, Liu CH. Expression of matrix metalloproteinase 2 in oral verruvous
carcinoma and squamous cell carcinoma. Zhong Nan Da Xue Xue
Bao Yi Xue Ban. 2005;30:650-2. |
|
|
|
|
|
20. Pradhan-Palikhe
P, Vesterinen T, Tarkkanen
J, Leivo I, Sorsa T, Salo T, et al. Plasma level of tissue inhibitor of matrix
metalloproteinase-1 but not that of matrix metalloproteinase-8 predicts
survival in head and neck squamous cell cancer. Oral
Oncol. 2010;46:514-8. |
|
|
|
|
|
21. Montel V, Kleeman J, Agarwal D, Spinella D, Kawai K, Tarin D.
Altered metastatic behavior of human breast cancer cells after experimental
manipulation of matrix metalloproteinase 8 gene expression. Cancer Res. 2004;64:1687-94. |
|
|
|
|
|
22. Korpi JT, Kervinen
V, Mäklin H, Väänänen A, Lahtinen M, Läärä E, et al. Collagenase-2 (matrix metalloproteinase-8) plays a protective role in
tongue cancer. Br J Cancer. 2008;98:766-75. |
|
|
|
|
|
23. Zucker S,
Cao J. Selective matrix metalloproteinase (MMP) inhibitors in cancer therapy:
ready for prime time? Cancer Biol Ther. 2009;8:2371-3. |
|
|
|
|
|
24. Wong MS, Sidik
SM, Mahmud R, Stanslas J. Molecular targets in the
discovery and development of novel antimetastatic
agents: current progress and future prospects. Clin Exp Pharmacol Physiol. 2013;40:307-19. |
|
|
|
|
|
25. Nakabayashi H, Yawata
T, Shimizu K. Anti-invasive and antiangiogenic effects of MMI-166 on malignant glioma
cells. BMC
Cancer. 2010;10:339. |
|
|
|
|
|
26. Mant TG, Bradford D, Amin DM, Pisupati J, Kambayashi Y, Yano Y, et al. Pharmacokinetics and safety assessments of high-dose and 4-week
treatment with S-3304, a novel matrix metalloproteinase inhibitor, in healthy
volunteers. Br J Clin Pharmacol.
2007;63:512-26. |
|